116 related articles for article (PubMed ID: 36095033)
1. Regio-selective synthesis and activity research on 7-icaritin norcantharidin conjugates.
Dong W; Wang X; Qian S; Wang Y; Zhao C
Nat Prod Res; 2024; 38(2):311-319. PubMed ID: 36095033
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Dual Target CPT-Ala-Nor Conjugates and Their Biological Activity Evaluation.
Zhao CK; Xu L; Wang XH; Bao YJ; Wang Y
Anticancer Agents Med Chem; 2019; 19(4):502-508. PubMed ID: 30663574
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 3- and 5-β-anhydroicaritine norcantharidin conjugates.
Lin H; Dong W; Zhao C; Wang X
Nat Prod Res; 2023 Nov; ():1-8. PubMed ID: 37950667
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Icaritin and β-anhydroicaritin Mannich Base Derivatives and Their Cytotoxic Activities on Three Human Cancer Cell Lines.
Nguyen VS; Shi L; Wang SC; Wang QA
Anticancer Agents Med Chem; 2017; 17(1):137-142. PubMed ID: 27039924
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cancer cell growth inhibitory activity of icaritin derivatives.
Wang C; Wu P; Shi JF; Jiang ZH; Wei XY
Eur J Med Chem; 2015 Jul; 100():139-50. PubMed ID: 26079090
[TBL] [Abstract][Full Text] [Related]
6. A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.
Huang X; Zhu D; Lou Y
Eur J Pharmacol; 2007 Jun; 564(1-3):26-36. PubMed ID: 17382317
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the
Li H; Li Y; Ao H; Fu J; Guo Y; Han M; Yan X; Chen X; Wang X
Drug Deliv; 2020 Dec; 27(1):1176-1187. PubMed ID: 32762483
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.
Tu GG; Zhan JF; Lv QL; Wang JQ; Kuang BH; Li SH
Med Chem; 2014 Jun; 10(4):376-81. PubMed ID: 23909288
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity.
Ibrahim TS; Sheha TA; Abo-Dya NE; AlAwadh MA; Alhakamy NA; Abdel-Samii ZK; Panda SS; Abuo-Rahma GEA; Mohamed MFA
Bioorg Chem; 2020 Jun; 99():103797. PubMed ID: 32247939
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological activity evaluation of campthothecin-HAA-Norcantharidin conjugates as antitumor agents in vitro.
Wang XH; Huang M; Zhao CK; Li C; Xu L
Chem Biol Drug Des; 2019 Jun; 93(6):986-992. PubMed ID: 30218487
[TBL] [Abstract][Full Text] [Related]
13. New Ferrocene Formates Bearing Isoxazole Moieties: Synthesis, Characterization, X-ray Crystallography, and Preliminarily Cytotoxicity against A549, HCT116, and MCF-7 Cell Lines.
Yong J; Lu C; Yang M; Wu X
Curr Pharm Des; 2022; 28(34):2835-2841. PubMed ID: 35996233
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin induces apoptosis of breast cancer cells: involvement of activities of mitogen activated protein kinases and signal transducers and activators of transcription.
Yang PY; Chen MF; Kao YH; Hu DN; Chang FR; Wu YC
Toxicol In Vitro; 2011 Apr; 25(3):699-707. PubMed ID: 21266192
[TBL] [Abstract][Full Text] [Related]
15. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
16. Involvement of caspase and MAPK activities in norcantharidin-induced colorectal cancer cell apoptosis.
Yang PY; Chen MF; Tsai CH; Hu DN; Chang FR; Wu YC
Toxicol In Vitro; 2010 Apr; 24(3):766-75. PubMed ID: 20040369
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.
Han HW; Qiu HY; Hu C; Sun WX; Yang RW; Qi JL; Wang XM; Lu GH; Yang YH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3237-3242. PubMed ID: 27262599
[TBL] [Abstract][Full Text] [Related]
18. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.
Guo Y; Zhang X; Meng J; Wang ZY
Eur J Pharmacol; 2011 May; 658(2-3):114-22. PubMed ID: 21376032
[TBL] [Abstract][Full Text] [Related]
19. The regio-selective synthesis of 10-hydroxy camptothecin norcantharidin conjugates and their biological activity evaluation
Zhao CK; Li C; Wang XH; Bao YJ; Yang FH; Huang M
R Soc Open Sci; 2018 Jun; 5(6):172317. PubMed ID: 30110459
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin.
Antoszczak M; Klejborowska G; Kruszyk M; Maj E; Wietrzyk J; Huczyński A
Chem Biol Drug Des; 2015 Dec; 86(6):1378-86. PubMed ID: 26058448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
